OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS · Real-Time Price · USD
18.67
-0.55 (-2.86%)
Mar 3, 2026, 4:00 PM EST - Market closed
OrthoPediatrics Revenue
In the year 2025, OrthoPediatrics had annual revenue of $236.35M with 15.45% growth. OrthoPediatrics had revenue of $61.61M in the quarter ending December 31, 2025, with 16.97% growth.
Revenue (ttm)
$236.35M
Revenue Growth
+15.45%
P/S Ratio
1.98
Revenue / Employee
$420,548
Employees
562
Market Cap
468.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 236.35M | 31.62M | 15.45% |
| Dec 31, 2024 | 204.73M | 56.00M | 37.65% |
| Dec 31, 2023 | 148.73M | 26.44M | 21.62% |
| Dec 31, 2022 | 122.29M | 24.24M | 24.72% |
| Dec 31, 2021 | 98.05M | 26.97M | 37.95% |
| Dec 31, 2020 | 71.08M | -1.47M | -2.03% |
| Dec 31, 2019 | 72.55M | 14.99M | 26.05% |
| Dec 31, 2018 | 57.56M | 11.94M | 26.17% |
| Dec 31, 2017 | 45.62M | 8.32M | 22.31% |
| Dec 31, 2016 | 37.30M | 6.29M | 20.30% |
| Dec 31, 2015 | 31.00M | 7.32M | 30.91% |
| Dec 31, 2014 | 23.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 854.40M |
| Orthofix Medical | 822.31M |
| Bioventus | 563.83M |
| Cerus | 206.13M |
| Cytek Biosciences | 201.49M |
| Pacific Biosciences of California | 160.01M |
| Beta Bionics | 100.25M |
| NeuroPace | 94.86M |
KIDS News
- 4 days ago - OrthoPediatrics to Participate in Upcoming Conferences - GlobeNewsWire
- 5 days ago - OrthoPediatrics Corp. (KIDS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 19 days ago - OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - GlobeNewsWire
- 4 weeks ago - OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity - GlobeNewsWire
- 7 weeks ago - OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance - GlobeNewsWire
- 3 months ago - OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches - GlobeNewsWire
- 4 months ago - OrthoPediatrics Corp. (KIDS) Q3 2025 Earnings Call Transcript - Seeking Alpha